September 13, 2023 (press release) –
With the FDA and the CDC authorization for the new vaccines targeting newer coronavirus variants, Walgreens stands ready to provide critical access to COVID-19 vaccines for all eligible individuals. Individuals will be able to schedule appointments immediately, with available appointments starting nationwide on Monday, September 18. Earlier appointments may be added on a rolling basis as stores receive vaccines this week.
Appointments can be scheduled by visiting Walgreens.com/ScheduleVaccine, using the Walgreens app or calling 1-800-WALGREENS. Additional appointments will be added daily as inventory arrives at stores.
Our trusted pharmacy teams are prepared to help keep our communities protected by ensuring everyone gets the appropriate prevention, testing and treatment they need this respiratory illness season.
The CDC is contracting with select pharmacies, including Walgreens, to offer free COVID-19 vaccinations to uninsured and underinsured adults through the Bridge Access Program. Walgreens remains focused on driving equitable and convenient access to life-saving vaccines.
Appointments can be scheduled by visiting Walgreens.com/ScheduleVaccine, using the Walgreens app or calling 1-800-WALGREENS. Additional appointments will be added daily as inventory arrives at stores.
Our trusted pharmacy teams are prepared to help keep our communities protected by ensuring everyone gets the appropriate prevention, testing and treatment they need this respiratory illness season.
The CDC is contracting with select pharmacies, including Walgreens, to offer free COVID-19 vaccinations to uninsured and underinsured adults through the Bridge Access Program. Walgreens remains focused on driving equitable and convenient access to life-saving vaccines.
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistribute or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.